Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study

Phase Ii ◽

Phase Ii Study ◽

Dose Finding ◽

Double Blind ◽

Double Blind Placebo ◽

Moderate Stress

Re: The Efficacy and Safety of PSD503 (Phenylephrine 20%, w/w) for Topical Application in Women with Stress Urinary Incontinence. A Phase II, Multicentre, Double-Blind, Placebo Controlled, 2-Way Cross Over Study

The Journal of Urology ◽

10.1016/j.juro.2012.08.157 ◽

2012 ◽

Vol 188 (6) ◽

pp. 2301-2302

Author(s):

Alan J. Wein

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

A phase II, multi-centre, double-blind, placebo-controlled, 2-way cross-over study to evaluate efficacy, plasma concentrations and safety of 0.25 mL of 20 % w/w PSD503 for topical application in female volunteer patients with stress urinary incontinence

http://isrctn.org/> ◽

10.1186/isrctn39853232 ◽

2012 ◽

Author(s):

Sheryl Caswell

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Plasma Concentrations ◽

Female Volunteer ◽

Double Blind ◽

The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2011.07.030 ◽

2011 ◽

Vol 159 (2) ◽

pp. 457-460 ◽

Cited By ~ 3

Author(s):

Dudley Robinson ◽

Paul Abrams ◽

Linda Cardozo ◽

Julie Ellis-Jones ◽

Pat Heath ◽

...

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-β-1a in moderately active ulcerative colitis

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2008.03778.x ◽

2008 ◽

Vol 28 (6) ◽

pp. 758-767 ◽

Cited By ~ 24

Author(s):

C. PENA-ROSSI ◽

S. SCHREIBER ◽

G. GOLUBOVIC ◽

A. MERTZ-NIELSEN ◽

J. PANES ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Study ◽

Dose Finding ◽

Active Ulcerative Colitis ◽

Interferon Β ◽

Double Blind ◽

The Efficacy and Safety of PSD503 (phenylephrine 20% w/w) for Topical Application in Women with Stress Urinary Incontinence. A Phase II, Multi-Centre, Double-Blind, Placebo-Controlled, Cross-Over Study

UroToday International Journal ◽

10.3834/uij.1939-4810.2008.06.39 ◽

2008 ◽

Author(s):

Linda Cardozo

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

A Randomized, Double‐Blind , Placebo‐Controlled , Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study

The Oncologist ◽

10.1634/theoncologist.2020-0679 ◽

2020 ◽

Vol 25 (11) ◽

Author(s):

Richard F. Riedel ◽

Karla V. Ballman ◽

Yao Lu ◽

Steven Attia ◽

Elizabeth T. Loggers ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Refractory

Stress urinary incontinence in postmenopausal women treated with oral estrogen (estriol) and an alpha-adrenoceptor-stimulating agent (phenylpropanolamine): A randomized double-blind placebo-controlled study

International Urogynecology Journal ◽

10.1007/bf00600025 ◽

1990 ◽

Vol 1 (2) ◽

pp. 74-79 ◽

Cited By ~ 39

Author(s):

S. Walter ◽

B. Kj�rgaard ◽

G. Lose ◽

J. T. Andersen ◽

L. Heisterberg ◽

...

Keyword(s):

Urinary Incontinence ◽

Postmenopausal Women ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Alpha Adrenoceptor ◽

Oral Estrogen

Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)

Annals of Oncology ◽

10.1093/annonc/mdw370.95 ◽

2016 ◽

Vol 27 ◽

pp. vi180

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Satake ◽

Y. Miyamoto ◽

H. Tanioka ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Circulation Journal ◽

10.1253/circj.cj-15-1112 ◽

2016 ◽

Vol 80 (3) ◽

pp. 668-676 ◽

Cited By ~ 18

Author(s):

Hiroyuki Tsutsui ◽

Shinichi Momomura ◽

Akira Yamashina ◽

Hisao Ogawa ◽

Hiroaki Shimokawa ◽

...

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Chronic Heart Failure ◽

Phase Ii ◽

Rate Control ◽

Phase Ii Study ◽

Japanese Patients ◽

Heart Rate Control ◽

Double Blind ◽

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial

International Journal of Urology ◽

10.1111/iju.14411 ◽

2020 ◽

Author(s):

Satoru Takahashi ◽

Kumiko Kato ◽

Mineo Takei ◽

Osamu Yokoyama ◽

Momokazu Gotoh

Keyword(s):

Urinary Incontinence ◽

Phase Ii ◽

Reuptake Inhibitor ◽

Early Phase ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor